Condition (MeSH)
Acidosis, Renal Tubular
ClinicalTrials.gov lists 9 trials for Acidosis, Renal Tubular or a narrower condition beneath it. Advicenne Pharma has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
9 of the 9 trials are tagged with Acidosis, Renal Tubular itself; the rest are tagged with a narrower condition beneath it.
When did Acidosis, Renal Tubular trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 2 |
| 2021 | 1 |
| 2018 | 2 |
| 2012 | 2 |
| 2011 | 1 |
| 2005 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 9 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Acidosis, Renal Tubular trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 2 |
| Not applicable | 2 |
| Observational | 5 |
How many Acidosis, Renal Tubular trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
| Terminated | 1 |
| Withdrawn | 2 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Acidosis, Renal Tubular trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Advicenne Pharma | 2 |
Which publications cover Acidosis, Renal Tubular? (13)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Renal tubular acidosis is highly prevalent in critically ill patients. | Critical care (London, England) | 2015 | Yes |
| Effect of topiramate on acid-base balance: extent, mechanism and effects. | British journal of clinical pharmacology | 2009 | Yes |
| Etiology of nephrocalcinosis in northern Indian children. | Pediatric nephrology (Berlin, Germany) | 2007 | Yes |
| Predictive value of kidney stone composition in the detection of metabolic abnormalities. | The American journal of medicine | 2003 | Yes |
| The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet | 2002 | Yes |
Showing 5 of 13 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.